← Back to Clinical Trials
Recruiting NCT06338904

NCT06338904 Brief Problem-solving Intervention in Different Formats for the Prevention of Suicide in Adults Over 50

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06338904
Status Recruiting
Phase
Sponsor University of Santiago de Compostela
Condition Suicide
Study Type INTERVENTIONAL
Enrollment 212 participants
Start Date 2023-09-01
Primary Completion 2026-05-31

Eligibility & Interventions

Sex All sexes
Min Age 50 Years
Max Age N/A
Study Type INTERVENTIONAL
Interventions
Problem-solving-based psychological intervention

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 212 participants in total. It began in 2023-09-01 with a primary completion date of 2026-05-31.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Suicide represents a personal tragedy and an enormous global public health problem. One of the most vulnerable groups is adults 50 years and older. Despite this stage of life is particularly amenable to the implementation of targeted suicide prevention strategies, we have few studies of the efficacy of psychological interventions, those that do exist have methodological limitations, and none were implemented in formats other than face-to-face, which limits their accessibility. There is a need for brief psychological interventions that can be administered in both face-to-face and remote formats, do not require long training periods, and are effective in different contexts: for example, problem-solving therapy. The main objective of this project is to evaluate the efficacy of a brief problem-solving psychological intervention for targeted suicide prevention in people aged 50 years and older, administered in face-to-face, conference call, and smartphone app formats. A randomized controlled trial will be performed. Participants will be recruited through healthcare centers in the Autonomous Community of Galicia (Spain). To be included, participants must: (a) be at least 50 years old, (b) reside in Galicia, and (c) present suicidal ideation. Subjects will be excluded if they: (a) present serious mental health or medical disorders; (b) have begun receiving psychological or psychopharmacological treatment in the previous two months or are participating in other suicide prevention research; (c) do not have an appropriate mobile device or sufficient fluency to communicate in Spanish, or have problems that make it impossible to participate; or (d) plan to move in the next 18 months. At pre-intervention information will be collected on sociodemographic, family, personal history, current suicide risk and other clinical variables. 212 participants will be randomly assigned to (1) a problem-solving-based psychological intervention delivered face-to-face (PSPI-FF; experimental group 1); (2) a problem-solving-based psychological intervention delivered via telephone conference call (PSPI-CC; experimental group 2); (3) a problem-solving-based psychological intervention delivered via a smartphone app (PSPI-A; experimental group 3); or (4) a usual care control group (UCCG). Participants in the experimental groups will complete the six sessions/modules of the interventions. Finally, subjects in all groups will be evaluated at post-intervention and 3, 6 and 12-month follow-ups.

Eligibility Criteria

Inclusion Criteria: * Be at least 50 years old * Reside in Galicia * Present suicidal ideation Exclusion Criteria: * Present serious mental health or medical disorders * Have begun receiving psychological or psychopharmacological treatment in the previous two months or are participating in other suicide prevention research * Do not have an appropriate mobile device or sufficient fluency to communicate in Spanish, or have problems that make it impossible to participate * Plan to move in the next 18 months.

Contact & Investigator

Central Contact

Fernando L. Vázquez González, PhD.

✉ fernandolino.vazquez@usc.es

📞 (00 34) 881811000

Principal Investigator

Fernando L. Vazquez González, PhD.

PRINCIPAL INVESTIGATOR

University of Santiago de Compostela

Frequently Asked Questions

Who can join the NCT06338904 clinical trial?

This trial is open to participants of all sexes, aged 50 Years or older, studying Suicide. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06338904 currently recruiting?

Yes, NCT06338904 is actively recruiting participants. Contact the research team at fernandolino.vazquez@usc.es for enrollment information.

Where is the NCT06338904 trial being conducted?

This trial is being conducted at Santiago de Compostela, Spain.

Who is sponsoring the NCT06338904 clinical trial?

NCT06338904 is sponsored by University of Santiago de Compostela. The principal investigator is Fernando L. Vazquez González, PhD. at University of Santiago de Compostela. The trial plans to enroll 212 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology